<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Daclatasvir Archives - ITPC MENA</title>
	<atom:link href="https://itpcmena.org/language/en/category/daclatasvir-en/feed/" rel="self" type="application/rss+xml" />
	<link>https://itpcmena.org/language/en/category/daclatasvir-en/</link>
	<description>International Treatment Preparedness Coalition</description>
	<lastBuildDate>Fri, 21 Jul 2017 17:31:11 +0000</lastBuildDate>
	<language>en-GB</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://i0.wp.com/itpcmena.org/wp-content/uploads/2016/01/cropped-logo-ITPC-MENA-HAUTE-DEF-1-1.png?fit=32%2C32&#038;ssl=1</url>
	<title>Daclatasvir Archives - ITPC MENA</title>
	<link>https://itpcmena.org/language/en/category/daclatasvir-en/</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">123726864</site>	<item>
		<title>ITPC MENA IN THE REGIONAL CONSULTATION ON ACCELERATING ACCESS TO THE CONTIUUM OF HIV …</title>
		<link>https://itpcmena.org/language/en/itpc-mena-in-the-regional-consultation-on-accelerating-access-to-the-contiuum-of-hiv-care-focus-on-hiv-testing/</link>
		
		<dc:creator><![CDATA[zakaria]]></dc:creator>
		<pubDate>Fri, 21 Jul 2017 17:46:53 +0000</pubDate>
				<category><![CDATA[Advocacy]]></category>
		<category><![CDATA[AIDS]]></category>
		<category><![CDATA[ARV]]></category>
		<category><![CDATA[Daclatasvir]]></category>
		<category><![CDATA[Dolutegravir]]></category>
		<category><![CDATA[Guidelines]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[Middle East]]></category>
		<category><![CDATA[Morocco]]></category>
		<category><![CDATA[North Africa]]></category>
		<category><![CDATA[REGION]]></category>
		<guid isPermaLink="false">http://itpcmena.org/?p=2973</guid>

					<description><![CDATA[<p>Beirut, Lebanon, 12–14 July 2017 By the end of 2015, the estimated number of people living with HIV in the Region had reached 330 000. With a continuously growing epidemic coupled with low coverage of ART, standing at 14% of people living with HIV, the number of deaths among people living with HIV was 15 [&#8230;]</p>
<p>Cet article <a href="https://itpcmena.org/language/en/itpc-mena-in-the-regional-consultation-on-accelerating-access-to-the-contiuum-of-hiv-care-focus-on-hiv-testing/">ITPC MENA IN THE REGIONAL CONSULTATION ON ACCELERATING ACCESS TO THE CONTIUUM OF HIV …</a> est apparu en premier sur <a href="https://itpcmena.org/language/en">ITPC MENA</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">2973</post-id>	</item>
		<item>
		<title>New WHO Guidance Report- Treatment Failure and Drug Resistance</title>
		<link>https://itpcmena.org/language/en/new-who-guidance-report-treatment-failure-and-drug-resistance/</link>
		
		<dc:creator><![CDATA[zakaria]]></dc:creator>
		<pubDate>Thu, 20 Jul 2017 16:54:35 +0000</pubDate>
				<category><![CDATA[Advocacy]]></category>
		<category><![CDATA[AIDS]]></category>
		<category><![CDATA[ARV]]></category>
		<category><![CDATA[Daclatasvir]]></category>
		<category><![CDATA[Dolutegravir]]></category>
		<category><![CDATA[Guidelines]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[The Global Fund]]></category>
		<guid isPermaLink="false">http://itpcmena.org/?p=2970</guid>

					<description><![CDATA[<p>WHO urges action against HIV drug resistance threat 20 JULY 2017 &#124; GENEVA &#8211; WHO alerts countries to the increasing trend of resistance to HIV drugs detailed in a report based on national surveys conducted in several countries. The Organization warns that this growing threat could undermine global progress in treating and preventing HIV infection if [&#8230;]</p>
<p>Cet article <a href="https://itpcmena.org/language/en/new-who-guidance-report-treatment-failure-and-drug-resistance/">New WHO Guidance Report- Treatment Failure and Drug Resistance</a> est apparu en premier sur <a href="https://itpcmena.org/language/en">ITPC MENA</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">2970</post-id>	</item>
		<item>
		<title>Amendment of the TRIPS Agreement</title>
		<link>https://itpcmena.org/language/en/amendment-of-the-trips-agreement/</link>
		
		<dc:creator><![CDATA[zakaria]]></dc:creator>
		<pubDate>Mon, 23 Jan 2017 11:00:58 +0000</pubDate>
				<category><![CDATA[Advocacy]]></category>
		<category><![CDATA[ARV]]></category>
		<category><![CDATA[Daclatasvir]]></category>
		<category><![CDATA[Dolutegravir]]></category>
		<category><![CDATA[HCV]]></category>
		<category><![CDATA[Health Financing]]></category>
		<category><![CDATA[Hepatitis]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[Intellectual Property]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Sofosbuvir]]></category>
		<category><![CDATA[TB]]></category>
		<guid isPermaLink="false">http://itpcmena.org/?p=2950</guid>

					<description><![CDATA[<p>WTO members on 6 December 2005 approved changes to the WTO’s intellectual property (TRIPS) agreement in order to make permanent a decision on patents and public health originally adopted in 2003. This was formally built into the TRIPS Agreement after acceptance of the Protocol amending the TRIPS Agreement by two thirds of the WTO’s members. [&#8230;]</p>
<p>Cet article <a href="https://itpcmena.org/language/en/amendment-of-the-trips-agreement/">Amendment of the TRIPS Agreement</a> est apparu en premier sur <a href="https://itpcmena.org/language/en">ITPC MENA</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">2950</post-id>	</item>
		<item>
		<title>Launch of Moroccan Generic Sofosbuvir: A Victory for the Wide-spread Use HCV Treatmen…</title>
		<link>https://itpcmena.org/language/en/2276/</link>
		
		<dc:creator><![CDATA[zakaria]]></dc:creator>
		<pubDate>Fri, 26 Jun 2015 13:46:11 +0000</pubDate>
				<category><![CDATA[ARV]]></category>
		<category><![CDATA[Daclatasvir]]></category>
		<category><![CDATA[HCV]]></category>
		<category><![CDATA[Hepatitis]]></category>
		<category><![CDATA[Intellectual Property]]></category>
		<category><![CDATA[Morocco]]></category>
		<category><![CDATA[North Africa]]></category>
		<category><![CDATA[Sofosbuvir]]></category>
		<guid isPermaLink="false">http://itpcmena.org/dev/itpc-mena/?p=2276</guid>

					<description><![CDATA[<p>According to the Ministry of Health, 625,000 people are infected by HCV, 1.6% of the general population of Morocco. Of those infected, 267,000 people have active chronic infection requiring treatment. Until recently, the management of HCV infection has been hampered by inadequate and costly treatments. The standard treatment involved a combination of pegylated interferon and [&#8230;]</p>
<p>Cet article <a href="https://itpcmena.org/language/en/2276/">Launch of Moroccan Generic Sofosbuvir: A Victory for the Wide-spread Use HCV Treatmen…</a> est apparu en premier sur <a href="https://itpcmena.org/language/en">ITPC MENA</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">2276</post-id>	</item>
		<item>
		<title>Treatment Advocates Denounce Gilead’s Embargo against Thousands of Tunisians Sufferin…</title>
		<link>https://itpcmena.org/language/en/treatment-advocates-denounce-gileads-embargo-against-thousands-of-tunisians-suffering-from-hcv-infection/</link>
		
		<dc:creator><![CDATA[zakaria]]></dc:creator>
		<pubDate>Wed, 20 May 2015 17:51:14 +0000</pubDate>
				<category><![CDATA[Advocacy]]></category>
		<category><![CDATA[ARV]]></category>
		<category><![CDATA[Daclatasvir]]></category>
		<category><![CDATA[HCV]]></category>
		<category><![CDATA[Health Financing]]></category>
		<category><![CDATA[Hepatitis]]></category>
		<category><![CDATA[Intellectual Property]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[North Africa]]></category>
		<category><![CDATA[Sofosbuvir]]></category>
		<guid isPermaLink="false">http://itpcmena.org/dev/itpc-mena/?p=2669</guid>

					<description><![CDATA[<p>The Tunisian Association of Fight against STDs and AIDS (ATL Tunis) and the International Treatment Preparedness Coalition in MENA Region (ITPC-MENA) denounce the refusal of Gilead Sciences to make their drug against the Hepatitis C Virus (HCV), sofosbuvir, available to Tunisian patients. &#8220;For months, thousands of patients have been desperately waiting for access to sofosbuvir. [&#8230;]</p>
<p>Cet article <a href="https://itpcmena.org/language/en/treatment-advocates-denounce-gileads-embargo-against-thousands-of-tunisians-suffering-from-hcv-infection/">Treatment Advocates Denounce Gilead’s Embargo against Thousands of Tunisians Sufferin…</a> est apparu en premier sur <a href="https://itpcmena.org/language/en">ITPC MENA</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">2669</post-id>	</item>
		<item>
		<title>The first Middle East and North Africa Community Advisory Board (MENA-CAB)</title>
		<link>https://itpcmena.org/language/en/the-first-middle-east-and-north-africa-community-advisory-board-mena-cab/</link>
		
		<dc:creator><![CDATA[zakaria]]></dc:creator>
		<pubDate>Thu, 10 Jul 2014 12:18:11 +0000</pubDate>
				<category><![CDATA[Advocacy]]></category>
		<category><![CDATA[AIDS]]></category>
		<category><![CDATA[Algeria]]></category>
		<category><![CDATA[ARV]]></category>
		<category><![CDATA[Daclatasvir]]></category>
		<category><![CDATA[Dolutegravir]]></category>
		<category><![CDATA[Guidelines]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[Intellectual Property]]></category>
		<category><![CDATA[Libya]]></category>
		<category><![CDATA[Middle East]]></category>
		<category><![CDATA[Morocco]]></category>
		<category><![CDATA[North Africa]]></category>
		<category><![CDATA[REGION]]></category>
		<category><![CDATA[Tunisia]]></category>
		<guid isPermaLink="false">http://itpcmena.org/?p=2924</guid>

					<description><![CDATA[<p>Casablanca, Morocco, 28 June-01 July 2014 Despite the fact that HIV prevalence in the countries of the Middle East and North Africa is believed to be low at least among the General Population, the rate of increase of new cases since 2001 makes this region home to one of the most fastest-growing epidemic in the [&#8230;]</p>
<p>Cet article <a href="https://itpcmena.org/language/en/the-first-middle-east-and-north-africa-community-advisory-board-mena-cab/">The first Middle East and North Africa Community Advisory Board (MENA-CAB)</a> est apparu en premier sur <a href="https://itpcmena.org/language/en">ITPC MENA</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">2924</post-id>	</item>
	</channel>
</rss>
